Search
for
Sort by
Research 751–780 of 1000+
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- Hair today, gone tomorrow
- Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactation
- Immune cell regulation of the hair cycle
- Novedades terapéuticas en tricología
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Hair Follicle Reconstruction and Stem Cells
- Pharmacological Treatment of Alopecia
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar